Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Archives of Pathology & Laboratory Medicine|December 9, 2008
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinomaLeonardo Faoro, Joann Y Hutto, Ravi Salgia, et al.The Journal of Biological Chemistry|April 3, 2010
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activationLeonardo Faoro, Patrick A Singleton, Gustavo M Cervantes, et al.Journal of Carcinogenesis|December 4, 2009
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancerLeonardo Faoro, Gustavo M Cervantes, Benjamin D Ferguson, et al.The Lancet. Oncology|July 8, 2021
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trialMarcia S Brose, Bruce Robinson, Steven I Sherman, et al.Thyroid : Official Journal of the American Thyroid Association|April 11, 2022
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid CancerJaume Capdevila, Arkadiy Klochikhin, Sophie Leboulleux, et al.Cancer Research|March 26, 2009
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaTanguy Y Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, et al.Plos One|July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic targetBenjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 InhibitorsRenata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, et al.Journal of Clinical Bioinformatics|May 24, 2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology databaseMosmi Surati, Matthew Robinson, Suvobroto Nandi, et al.Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.Pageof 2